Vaccine Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Vaccine Clinical Trials in Mexico

Vaccine Clinical Trials in Mexico – Human Trials LATAM

Vaccine clinical trials play a crucial role in ensuring the safety and efficacy of new immunization strategies. In Mexico, a country committed to public health, the pursuit of effective vaccines against various diseases has gained significant momentum.

This blog explores the landscape of vaccine clinical trials in Mexico, shedding light on the process, importance, and impact of these trials in advancing public health initiatives.

The Regulatory Framework

Before delving into the details of vaccine clinical trials in Mexico, it is essential to understand the regulatory framework that governs these studies. The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is responsible for overseeing clinical trials and ensuring compliance with national and international standards.

COFEPRIS provides guidance on protocol design, participant safety, and ethical considerations to maintain high standards in clinical research.

Collaboration with International Partners

Mexico has fostered collaboration with international organizations and pharmaceutical companies to conduct vaccine clinical trials. These partnerships facilitate the exchange of knowledge, resources, and expertise, contributing to the acceleration of vaccine development.

By participating in multinational trials, Mexico ensures that its population has access to cutting-edge vaccines while also contributing valuable data to the global scientific community.

COVID-19 Vaccine Trials

In the wake of the COVID-19 pandemic, Mexico has played a significant role in vaccine clinical trials. Multiple vaccine candidates underwent rigorous testing in the country to assess their safety and efficacy.

These trials adhered to the highest scientific and ethical standards, ensuring the well-being of participants. By hosting COVID-19 vaccine trials, Mexico has not only contributed to the global effort to combat the pandemic but has also gained firsthand knowledge and experience in conducting large-scale clinical trials.

Engaging Diverse Populations

Vaccine clinical trials in Mexico have prioritized inclusivity and the representation of diverse populations. This approach acknowledges the importance of studying the vaccine’s impact across different ethnicities, age groups, and socioeconomic backgrounds.

By including underrepresented communities, Mexico aims to ensure that vaccines are effective and safe for all its citizens, thus reducing health disparities.

Vaccine Clinical Trials in Mexico

Vaccine Clinical Trials in Mexico

Impact on Public Health

Vaccine clinical trials in Mexico have a profound impact on public health. By evaluating the safety and efficacy of vaccines, these trials provide crucial evidence for regulatory approvals and inform national immunization policies.

Successful trials lead to the availability of effective vaccines, protecting the population from preventable diseases and reducing the burden on healthcare systems. Moreover, these trials contribute to the scientific knowledge surrounding immunization, allowing for continuous improvement and innovation in vaccine development.

Enhancing Research Infrastructure

Through hosting vaccine clinical trials, Mexico has made substantial investments in research infrastructure. The establishment of clinical trial centers, equipped with state-of-the-art facilities and expert personnel, not only supports ongoing trials but also strengthens the country’s capacity to conduct future research.

This infrastructure can be utilized beyond vaccine trials to advance other areas of clinical research, benefiting the overall healthcare system.

Conclusion

Vaccine clinical trials in Mexico are pivotal in safeguarding public health and contributing to global scientific knowledge. The collaboration with international partners, focus on inclusivity, and commitment to high regulatory standards have positioned Mexico as a key player in vaccine development.

By hosting trials, the country not only gains access to cutting-edge vaccines but also contributes to the improvement of healthcare infrastructure and policies. As Mexico continues to prioritize clinical research, it reinforces its commitment to the well-being of its citizens and strengthens its role in the global fight against infectious diseases.

Vaccine Clinical Trials in Mexic

Source: Roche

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Vaccine Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Vaccine Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Vaccine Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Vaccine Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Vaccine Clinical Trials in Mexico

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Vaccine Clinical Trials in Mexico

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Vaccine Clinical Trials in Mexico

The Cohortias Team

Vaccine Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Vaccine Clinical Trials in Mexico

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe